Artwork

Content provided by Sharon Quimby and American Academy of Neurology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sharon Quimby and American Academy of Neurology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

May 2024 Neurology Recall: Topics in Neuro-Oncology

1:09:47
 
Share
 

Manage episode 416005855 series 113518
Content provided by Sharon Quimby and American Academy of Neurology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sharon Quimby and American Academy of Neurology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The May 2024 replay features four episodes on neuro-oncology for brain cancer awareness month. The episode begins with Dr. Philipp Karschnia discussing the assessment of whether MTHFR polymorphisms affect the risk for leukoencephalopathy. The episode continues with Dr. Ingo Mellinghoff discussing new treatment opinions for isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. The third interview leads into a conversation with Dr. Linda Liau on the study of vaccine-based therapy for GBM. The episode concludes with Dr. Teddy Totimeh talking about brain tumor programs in Asia and Africa.

Podcast Links:

MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients

New Treatment for IDH mt Gliomas

Study of Vaccine-Based Therapy for GBM

Brain Tumor Programs in Asia and Africa

Article Links:

https://doi.org/10.1212/WNL.0000000000207670

https://www.nejm.org/doi/full/10.1056/NEJMoa2304194

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

https://doi.org/10.1016/j.wneu.2023.04.067

Disclosures can be found at Neurology.org.

  continue reading

1125 episodes

Artwork
iconShare
 
Manage episode 416005855 series 113518
Content provided by Sharon Quimby and American Academy of Neurology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sharon Quimby and American Academy of Neurology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The May 2024 replay features four episodes on neuro-oncology for brain cancer awareness month. The episode begins with Dr. Philipp Karschnia discussing the assessment of whether MTHFR polymorphisms affect the risk for leukoencephalopathy. The episode continues with Dr. Ingo Mellinghoff discussing new treatment opinions for isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. The third interview leads into a conversation with Dr. Linda Liau on the study of vaccine-based therapy for GBM. The episode concludes with Dr. Teddy Totimeh talking about brain tumor programs in Asia and Africa.

Podcast Links:

MTHFR Polymorphisms and Leukoencephalopathy Risk in CNS Lymphoma Patients

New Treatment for IDH mt Gliomas

Study of Vaccine-Based Therapy for GBM

Brain Tumor Programs in Asia and Africa

Article Links:

https://doi.org/10.1212/WNL.0000000000207670

https://www.nejm.org/doi/full/10.1056/NEJMoa2304194

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

https://doi.org/10.1016/j.wneu.2023.04.067

Disclosures can be found at Neurology.org.

  continue reading

1125 episodes

सभी एपिसोड

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide